KRAS INHIBITOR
Lupin signs second partnership for its oncology pipeline, this time with German drug maker BIBI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially...04 Sep, 2019, 05.51 PM IST
Load More